Chemed Co. (NYSE:CHE) Director Sells $238,988.00 in Stock

Chemed Co. (NYSE:CHE) Director George J. Walsh III sold 400 shares of Chemed stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the transaction, the director now owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Chemed Stock Down 0.2 %

CHE stock opened at $599.04 on Monday. The stock’s 50 day moving average is $574.54 and its 200-day moving average is $575.46. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The firm has a market capitalization of $9.07 billion, a PE ratio of 32.24, a P/E/G ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. During the same period in the prior year, the firm earned $4.71 earnings per share. Chemed’s revenue was up 7.6% compared to the same quarter last year. On average, equities research analysts anticipate that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Monday, August 12th. This is an increase from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is presently 10.76%.

Hedge Funds Weigh In On Chemed

Several institutional investors have recently modified their holdings of CHE. Centaurus Financial Inc. grew its stake in Chemed by 334.6% in the 2nd quarter. Centaurus Financial Inc. now owns 2,147 shares of the company’s stock valued at $1,165,000 after purchasing an additional 1,653 shares during the period. Sanctuary Advisors LLC purchased a new stake in Chemed during the second quarter worth about $1,955,000. Quarry LP raised its position in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after acquiring an additional 166 shares during the period. Second Line Capital LLC boosted its stake in Chemed by 7.6% in the second quarter. Second Line Capital LLC now owns 3,925 shares of the company’s stock valued at $2,130,000 after acquiring an additional 277 shares during the last quarter. Finally, Creative Planning grew its position in shares of Chemed by 2.8% during the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock valued at $667,000 after acquiring an additional 34 shares during the period. 95.85% of the stock is owned by institutional investors.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.